This is the fourth issue of COVID-19 Report. We point you to the latest quality science on the pandemic. If you come across unfamiliar terms, there is a glossary at the bottom of the article.
Many journalists, including us, are finding the quantity of science reports on COVID-19 overwhelming. We introduce a new occasional column to help make sense of the information overload. The aim of this occasional column, which we’re calling COVID-19 Report, will be to alert reporters in South Africa (and anyone else who is interested) to the best and most important science, and also clear up misconceptions.
Scientific research on COVID-19 has been published at an unprecedented scale and speed, but some fear that this is at the cost of scientific rigour. Adele Baleta explores the pros and cons of high-speed science.
Unless timely action is taken, South Africa could be faced with a new form of “pharmaceutical apartheid,” like that experienced in the early days of the AIDS response, writes Professor Yousuf Vawda & Professor Brook K. Baker.
South Africa’s strategy to defeat COVID-19 (Coronavirus Disease 2019) is to lockdown the country and upscale testing to quickly identify individuals who may have been infected with the SARS-CoV-2 virus.
South Africa will participate in a large new trial of four potential treatments for COVID-19. Marcus Low argues that the trial takes the right approach in establishing whether any of the potential treatments work.